Samuel Almazan-Alvarez
Cuautitlan Izcalli, MEX 54740, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Four New Menadione Thioderivatives, Potential Antineoplastic Candidates: In Silico and PARP-1 Inhibition Studies.
Journal: Molecules (Basel, Switzerland)
Published: January 08, 2026
Characterization of the lysine decarboxylase activity of human ornithine decarboxylase and identification of lysine-like inhibitors.
Journal: Archives of biochemistry and biophysics
Published: September 17, 2025
Effect of Different Karyophilic Peptides on Physical Characteristics and In Vitro Transfection Efficiency of Chitosan-Plasmid Nanoparticles as Nonviral Gene Delivery Systems.
Journal: Molecular biotechnology
Published: October 19, 2023
Anti-Diabetic Activity of Glycyrrhetinic Acid Derivatives FC-114 and FC-122: Scale-Up, In Silico, In Vitro, and In Vivo Studies.
Journal: International journal of molecular sciences
Published: June 30, 2023
In Vivo and Ex Vivo Evaluation of 1,3-Thiazolidine-2,4-Dione Derivatives as Euglycemic Agents.
Journal: PPAR research
Published: June 30, 2021
Current molecular aspects in the development and treatment of diabetes.
Journal: Journal of physiology and biochemistry
Published: July 01, 2019
Study of new interactions of glitazone's stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins.
Journal: Biochemical pharmacology
Published: April 19, 2017
In silico design, chemical synthesis and toxicological evaluation of 1,3-thiazolidine-2,4-dione derivatives as PPARγ agonists.
Journal: Regulatory toxicology and pharmacology : RTP
Published: September 21, 2016
Current Advances in the Biochemical and Physiological Aspects of the Treatment of Type 2 Diabetes Mellitus with Thiazolidinediones.
Journal: PPAR research
Published: March 18, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026